Author Correction: Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasis

Correction to: Scientific Reports 10.1038/s41598-017-08422-y, published online 21 August 2017

This article contains an error in Figure 5.

As a result of an error during figure assembly, images collected for the same sample were used to represent different conditions in Figure 5A, timepoint 0h. The corrected Figure 5 and its accompanying legend appear below.

Figure 5.

Pretreatment of miR-374a in MDA-MB-231 attenuates the responses to ISL. (A) Representative images of wound healing assay in miR-NC and miR-374a mimic transfected groups after 24 h ISL treatment. (B) Chamber migration and invasion assay analysis of the effect of miR-374a transfection on breast cancer motile ability with ISL interference. (C) Percentages of closures of the wound in miR-374a-modulated MDA-MB-231 cells by 24 h exposure to ISL. (D,E) Percentages of the number of cells located on the lower side of chambers and Matrigel-coated chambers in the presence of ISL with miR-374a interference. Data represent the mean ± s.d. *P < 0.05, **P < 0.01.